Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,592 | 44,888 | 53,885 | 53,621 | 63,241 |
| Marketable Securities | 1,796 | 934 | 610 | 625 | 557 |
| Receivables | 4,078 | 6,871 | 1,872 | 1,293 | 2,643 |
| Inventories | 720 | 430 | 2,009 | 4,542 | 2,565 |
| Other current assets | 298 | 1,250 | 0 | 3,221 | 0 |
| TOTAL | $83,278 | $55,780 | $59,796 | $64,722 | $73,362 |
| Non-Current Assets | |||||
| PPE Net | 984 | 809 | 826 | 985 | 1,374 |
| Investments And Advances | 27,569 | 13,563 | 14,038 | 14,038 | 14,038 |
| Intangibles | 13,015 | 13,143 | 16,289 | 13,674 | 17,268 |
| Other Non-Current Assets | 9,392 | 8,274 | 8,536 | 9,212 | 3,028 |
| TOTAL | $50,960 | $35,789 | $39,689 | $37,909 | $35,708 |
| Total Assets | $134,238 | $91,569 | $99,485 | $102,631 | $109,070 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,697 | 1,825 | 5,452 | 5,113 | 4,827 |
| Accrued Expenses | 2,858 | 2,354 | 2,089 | 2,834 | 2,121 |
| TOTAL | $5,555 | $4,179 | $7,541 | $7,947 | $6,948 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 34,689 | 21,659 | 21,374 | 21,478 | 21,529 |
| TOTAL | $37,156 | $24,051 | $21,582 | $21,689 | $21,751 |
| Total Liabilities | $42,711 | $28,230 | $29,123 | $29,636 | $28,699 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,394 | 12,394 | 10,091 | 9,902 | 9,635 |
| Common Shares | 1,240 | 1,010 | 1,010 | 979 | 964 |
| Retained earnings | -556,811 | -540,364 | -532,032 | -523,908 | -512,074 |
| Other shareholders' equity | -1,541 | -3,924 | -3,588 | -2,762 | -3,897 |
| TOTAL | $91,527 | $63,339 | $70,362 | $72,995 | $80,371 |
| Total Liabilities And Equity | $134,238 | $91,569 | $99,485 | $102,631 | $109,070 |